Novartis Ag (NVSEF) EPS (Weighted Average and Diluted) Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) EPS (Weighted Average and Diluted) Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -2.12%
Jun 30, 2024 -13.59%
Dec 31, 2023 63.23%
Sep 30, 2023 29.68%
Jun 30, 2023 28.26%
Mar 31, 2023 15.61%
Dec 31, 2022 4,696.14%
Sep 30, 2022 -14.01%
Jun 30, 2022 -98.73%
Mar 31, 2022 -4.26%
Dec 31, 2021 4,350.47%
Sep 30, 2021 -3.07%
Jun 30, 2021 -98.17%
Mar 31, 2021 20.73%
Dec 31, 2020 311.88%
Sep 30, 2020 46.85%
Jun 30, 2020 3,421.65%
Mar 31, 2020 1,199.00%
Jun 30, 2019 2,802.38%
Mar 31, 2019 -1,101.89%